← Leaderboards
Raphaela Goldbach-Mansky
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
- Emily Ricotta$0
- Alan Sher$549,303
- Iain Fraser$0
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineInterleukin-1InterferonsOrganLifeImmuneExanthemaMediatingFeverSourceResponseMonocyteMendelian DisorderSignal TransductionAutoinflammatoryInflammationProductionSamplingGenesBiological MarkersMonitorLung DiseasesGeneticGenetic Signature
Grant awards (12)
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,978,290
ZIA · FY2025 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,682,681
ZIA · FY2024 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,606,186
ZIA · FY2023 · AI · contact PI
Longitudinal IFN signature response and cytokine profiling in patients with severe COVID infections$10,739
ZIA · FY2023 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,135,710
ZIA · FY2022 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$1,902,292
ZIA · FY2021 · AI · contact PI
Longitudinal IFN signature response and cytokine profiling in patients with severe COVID infections$35,545
ZIA · FY2021 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,773,603
ZIA · FY2020 · AI · contact PI
Longitudinal IFN signature response and cytokine profiling in patients with severe COVID infections$90,817
ZIA · FY2020 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,449,242
ZIA · FY2019 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases$2,904,544
ZIA · FY2018 · AI · contact PI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases$1,863,256
ZIA · FY2017 · AI · contact PI